TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.

Richard A Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.